Our team recently attended the SingularityU South Africa Summit, where leaders, tech pioneers and industry experts came together to discuss the transformative power of technology. We left the summit inspired by the future of healthcare both on the African continent and beyond.
We interviewed Professor Linda-Gail Bekker to learn more about her prolific career. Bekker is a Professor of Medicine and Director of the Desmond Tutu HIV Centre at the University of Cape Town. She is also CEO of the Desmond Tutu HIV Foundation. In this interview, she speaks about the current HIV landscape, why HIV vaccines are critical, the importance of collaboration and the exciting work of the BRILLIANT consortium.
We interviewed Professor Glenda Gray to gain more insight on the significance of the USAID-funded BRILLIANT Consortium.
BioInformatiCo is proud to announce our partnership with the BRILLIANT Consortium, a USAID-funded Cooperative Agreement dedicated to accelerating HIV vaccine discovery and development in Africa. This collaboration between African scientists and institutions, led by the South African Medical Research Council (SAMRC), is a significant milestone in the fight against HIV.
We love working with Engineers at BioInformatiCo! Engineers bring a systematic approach, problem-solving skills, automation capabilities, cost-efficiency and a focus on continuous improvement to data management teams. These attributes greatly enhance the effectiveness and quality of data management operations while allowing human team members to concentrate on more strategic and value-added activities.
Clinical trials are complex endeavours requiring specialised management, a role often filled by Contract Research Organisations (CROs). CROs are crucial in handling various aspects of a clinical trial, from study set-up to closeout. At BioInformatiCo, we employ state-of-the-art tools for continuous data monitoring and prioritise fast and efficient resolution of data queries. Our approach ensures data integrity is maintained consistently throughout the trial.